Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label, Single Arm Study to Evaluate JWCAR201 Treating B Cell Driven Hematology Malignancy and Autoimmune Diseases

NCT06567080 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT06567080
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06567080 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label, Single Arm Study to Evaluate JWCAR201 Treating B Cell Driven Hematology Malignancy and Autoimmune Diseases
Lead sponsor
RenJi Hospital
Phase
Phase 1
Overall status
Not yet recruiting
Start date
September 30, 2024
Completion date
March 31, 2027
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autoimmune diseases, b-cell tumors, large b-cell lymphoma, lupus erythematosus, systemic